Vyvanse 50 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FWJSB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,675
Award facts
- Contract value 100% obligated
- $2,675.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,675.40 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention-deficit/hyperactivity disorder and binge eating disorder. The contract, which commenced on July 25, 2025, with an ultimate completion date of July 28, 2025, utilizes firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio with the DLA encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order represents routine pharmaceutical procurement supporting Department of Defense medical supply chain operations, consistent with AmerisourceBergen's established role as a primary pharmaceutical supplier for military healthcare programs and other federal health systems.
Quick answers
Who was awarded contract SPE2DB25FWJSB?
SPE2DB25FWJSB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FWJSB worth?
The government has obligated $2,675 on SPE2DB25FWJSB.
Is contract SPE2DB25FWJSB an order under another contract?
Yes. SPE2DB25FWJSB is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJSB competed?
The extent of competition for SPE2DB25FWJSB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award